Report Thumbnail
Product Code LP0914710472QBW
Published Date 2023/2/22
English103 PagesGlobal

Global AI in Genomics Market Growth (Status and Outlook) 2023-2029Pharmaceutical_LifeSciense Market


Report Thumbnail
Product Code LP0914710472QBW◆The Feb 2026 edition is also likely available. We will check with the publisher immediately.
Published Date 2023/2/22
English 103 PagesGlobal

Global AI in Genomics Market Growth (Status and Outlook) 2023-2029Pharmaceutical_LifeSciense Market



Abstract


Summary

LPI (LP Information)' newest research report, the “AI in Genomics Industry Forecast” looks at past sales and reviews total world AI in Genomics sales in 2022, providing a comprehensive analysis by region and market sector of projected AI in Genomics sales for 2023 through 2029. With AI in Genomics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world AI in Genomics industry.
This Insight Report provides a comprehensive analysis of the global AI in Genomics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on AI in Genomics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global AI in Genomics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for AI in Genomics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global AI in Genomics.
The global AI in Genomics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for AI in Genomics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for AI in Genomics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for AI in Genomics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key AI in Genomics players cover IBM Corporation, Microsoft Corporation, NVIDIA Corporation, Deep Genomics, BenevolentAI, Fabric Genomics Inc., Verge Genomics, MolecularMatch Inc. and Lifebit, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of AI in Genomics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
On-Premises
Cloud-Based
Segmentation by application
Translational Precision Medicine
Clinical Diagnostics and Research
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
IBM Corporation
Microsoft Corporation
NVIDIA Corporation
Deep Genomics
BenevolentAI
Fabric Genomics Inc.
Verge Genomics
MolecularMatch Inc.
Lifebit
DNAnexus Inc.

Table of Contents

  • 1 Scope of the Report

    • 1.1 Market Introduction
    • 1.2 Years Considered
    • 1.3 Research Objectives
    • 1.4 Market Research Methodology
    • 1.5 Research Process and Data Source
    • 1.6 Economic Indicators
    • 1.7 Currency Considered
    • 1.8 Market Estimation Caveats
  • 2 Executive Summary

    • 2.1 World Market Overview
      • 2.1.1 Global AI in Genomics Market Size 2018-2029
      • 2.1.2 AI in Genomics Market Size CAGR by Region 2018 VS 2022 VS 2029
    • 2.2 AI in Genomics Segment by Type
      • 2.2.1 On-Premises
      • 2.2.2 Cloud-Based
    • 2.3 AI in Genomics Market Size by Type
      • 2.3.1 AI in Genomics Market Size CAGR by Type (2018 VS 2022 VS 2029)
      • 2.3.2 Global AI in Genomics Market Size Market Share by Type (2018-2023)
    • 2.4 AI in Genomics Segment by Application
      • 2.4.1 Translational Precision Medicine
      • 2.4.2 Clinical Diagnostics and Research
      • 2.4.3 Others
    • 2.5 AI in Genomics Market Size by Application
      • 2.5.1 AI in Genomics Market Size CAGR by Application (2018 VS 2022 VS 2029)
      • 2.5.2 Global AI in Genomics Market Size Market Share by Application (2018-2023)
  • 3 AI in Genomics Market Size by Player

    • 3.1 AI in Genomics Market Size Market Share by Players
      • 3.1.1 Global AI in Genomics Revenue by Players (2018-2023)
      • 3.1.2 Global AI in Genomics Revenue Market Share by Players (2018-2023)
    • 3.2 Global AI in Genomics Key Players Head office and Products Offered
    • 3.3 Market Concentration Rate Analysis
      • 3.3.1 Competition Landscape Analysis
      • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
    • 3.4 New Products and Potential Entrants
    • 3.5 Mergers & Acquisitions, Expansion
  • 4 AI in Genomics by Regions

    • 4.1 AI in Genomics Market Size by Regions (2018-2023)
    • 4.2 Americas AI in Genomics Market Size Growth (2018-2023)
    • 4.3 APAC AI in Genomics Market Size Growth (2018-2023)
    • 4.4 Europe AI in Genomics Market Size Growth (2018-2023)
    • 4.5 Middle East & Africa AI in Genomics Market Size Growth (2018-2023)
  • 5 Americas

    • 5.1 Americas AI in Genomics Market Size by Country (2018-2023)
    • 5.2 Americas AI in Genomics Market Size by Type (2018-2023)
    • 5.3 Americas AI in Genomics Market Size by Application (2018-2023)
    • 5.4 United States
    • 5.5 Canada
    • 5.6 Mexico
    • 5.7 Brazil
  • 6 APAC

    • 6.1 APAC AI in Genomics Market Size by Region (2018-2023)
    • 6.2 APAC AI in Genomics Market Size by Type (2018-2023)
    • 6.3 APAC AI in Genomics Market Size by Application (2018-2023)
    • 6.4 China
    • 6.5 Japan
    • 6.6 Korea
    • 6.7 Southeast Asia
    • 6.8 India
    • 6.9 Australia
  • 7 Europe

    • 7.1 Europe AI in Genomics by Country (2018-2023)
    • 7.2 Europe AI in Genomics Market Size by Type (2018-2023)
    • 7.3 Europe AI in Genomics Market Size by Application (2018-2023)
    • 7.4 Germany
    • 7.5 France
    • 7.6 UK
    • 7.7 Italy
    • 7.8 Russia
  • 8 Middle East & Africa

    • 8.1 Middle East & Africa AI in Genomics by Region (2018-2023)
    • 8.2 Middle East & Africa AI in Genomics Market Size by Type (2018-2023)
    • 8.3 Middle East & Africa AI in Genomics Market Size by Application (2018-2023)
    • 8.4 Egypt
    • 8.5 South Africa
    • 8.6 Israel
    • 8.7 Turkey
    • 8.8 GCC Countries
  • 9 Market Drivers, Challenges and Trends

    • 9.1 Market Drivers & Growth Opportunities
    • 9.2 Market Challenges & Risks
    • 9.3 Industry Trends
  • 10 Global AI in Genomics Market Forecast

    • 10.1 Global AI in Genomics Forecast by Regions (2024-2029)
      • 10.1.1 Global AI in Genomics Forecast by Regions (2024-2029)
      • 10.1.2 Americas AI in Genomics Forecast
      • 10.1.3 APAC AI in Genomics Forecast
      • 10.1.4 Europe AI in Genomics Forecast
      • 10.1.5 Middle East & Africa AI in Genomics Forecast
    • 10.2 Americas AI in Genomics Forecast by Country (2024-2029)
      • 10.2.1 United States AI in Genomics Market Forecast
      • 10.2.2 Canada AI in Genomics Market Forecast
      • 10.2.3 Mexico AI in Genomics Market Forecast
      • 10.2.4 Brazil AI in Genomics Market Forecast
    • 10.3 APAC AI in Genomics Forecast by Region (2024-2029)
      • 10.3.1 China AI in Genomics Market Forecast
      • 10.3.2 Japan AI in Genomics Market Forecast
      • 10.3.3 Korea AI in Genomics Market Forecast
      • 10.3.4 Southeast Asia AI in Genomics Market Forecast
      • 10.3.5 India AI in Genomics Market Forecast
      • 10.3.6 Australia AI in Genomics Market Forecast
    • 10.4 Europe AI in Genomics Forecast by Country (2024-2029)
      • 10.4.1 Germany AI in Genomics Market Forecast
      • 10.4.2 France AI in Genomics Market Forecast
      • 10.4.3 UK AI in Genomics Market Forecast
      • 10.4.4 Italy AI in Genomics Market Forecast
      • 10.4.5 Russia AI in Genomics Market Forecast
    • 10.5 Middle East & Africa AI in Genomics Forecast by Region (2024-2029)
      • 10.5.1 Egypt AI in Genomics Market Forecast
      • 10.5.2 South Africa AI in Genomics Market Forecast
      • 10.5.3 Israel AI in Genomics Market Forecast
      • 10.5.4 Turkey AI in Genomics Market Forecast
      • 10.5.5 GCC Countries AI in Genomics Market Forecast
    • 10.6 Global AI in Genomics Forecast by Type (2024-2029)
    • 10.7 Global AI in Genomics Forecast by Application (2024-2029)
  • 11 Key Players Analysis

    • 11.1 IBM Corporation
      • 11.1.1 IBM Corporation Company Information
      • 11.1.2 IBM Corporation AI in Genomics Product Offered
      • 11.1.3 IBM Corporation AI in Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.1.4 IBM Corporation Main Business Overview
      • 11.1.5 IBM Corporation Latest Developments
    • 11.2 Microsoft Corporation
      • 11.2.1 Microsoft Corporation Company Information
      • 11.2.2 Microsoft Corporation AI in Genomics Product Offered
      • 11.2.3 Microsoft Corporation AI in Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.2.4 Microsoft Corporation Main Business Overview
      • 11.2.5 Microsoft Corporation Latest Developments
    • 11.3 NVIDIA Corporation
      • 11.3.1 NVIDIA Corporation Company Information
      • 11.3.2 NVIDIA Corporation AI in Genomics Product Offered
      • 11.3.3 NVIDIA Corporation AI in Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.3.4 NVIDIA Corporation Main Business Overview
      • 11.3.5 NVIDIA Corporation Latest Developments
    • 11.4 Deep Genomics
      • 11.4.1 Deep Genomics Company Information
      • 11.4.2 Deep Genomics AI in Genomics Product Offered
      • 11.4.3 Deep Genomics AI in Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.4.4 Deep Genomics Main Business Overview
      • 11.4.5 Deep Genomics Latest Developments
    • 11.5 BenevolentAI
      • 11.5.1 BenevolentAI Company Information
      • 11.5.2 BenevolentAI AI in Genomics Product Offered
      • 11.5.3 BenevolentAI AI in Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.5.4 BenevolentAI Main Business Overview
      • 11.5.5 BenevolentAI Latest Developments
    • 11.6 Fabric Genomics Inc.
      • 11.6.1 Fabric Genomics Inc. Company Information
      • 11.6.2 Fabric Genomics Inc. AI in Genomics Product Offered
      • 11.6.3 Fabric Genomics Inc. AI in Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.6.4 Fabric Genomics Inc. Main Business Overview
      • 11.6.5 Fabric Genomics Inc. Latest Developments
    • 11.7 Verge Genomics
      • 11.7.1 Verge Genomics Company Information
      • 11.7.2 Verge Genomics AI in Genomics Product Offered
      • 11.7.3 Verge Genomics AI in Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.7.4 Verge Genomics Main Business Overview
      • 11.7.5 Verge Genomics Latest Developments
    • 11.8 MolecularMatch Inc.
      • 11.8.1 MolecularMatch Inc. Company Information
      • 11.8.2 MolecularMatch Inc. AI in Genomics Product Offered
      • 11.8.3 MolecularMatch Inc. AI in Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.8.4 MolecularMatch Inc. Main Business Overview
      • 11.8.5 MolecularMatch Inc. Latest Developments
    • 11.9 Lifebit
      • 11.9.1 Lifebit Company Information
      • 11.9.2 Lifebit AI in Genomics Product Offered
      • 11.9.3 Lifebit AI in Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.9.4 Lifebit Main Business Overview
      • 11.9.5 Lifebit Latest Developments
    • 11.10 DNAnexus Inc.
      • 11.10.1 DNAnexus Inc. Company Information
      • 11.10.2 DNAnexus Inc. AI in Genomics Product Offered
      • 11.10.3 DNAnexus Inc. AI in Genomics Revenue, Gross Margin and Market Share (2018-2023)
      • 11.10.4 DNAnexus Inc. Main Business Overview
      • 11.10.5 DNAnexus Inc. Latest Developments
  • 12 Research Findings and Conclusion

USD 3,660 or Partial Purchase
*Prices are subject to change by the publisher.
© 2026 ShareFair Inc.